PL2206710T3 - Pochodne indolu jako agoniści receptora S1P1 - Google Patents

Pochodne indolu jako agoniści receptora S1P1

Info

Publication number: PL2206710T3
Authority: PL; Poland
Prior art keywords: receptor agonists; indole derivatives; indole; derivatives; agonists
Prior art date: 2006-12-21

Application number

PL10158582T

Other languages

English (en)

Inventor

Mahmood Ahmed

James Myatt

David Norton

Dean Andrew Rivers

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-21

Filing date

2007-12-19

Publication date

2012-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39283563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2206710(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-21 Priority claimed from GB0625647A external-priority patent/GB0625647D0/en

2007-04-19 Priority claimed from GB0707615A external-priority patent/GB0707615D0/en

2007-12-19 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2012-11-30 Publication of PL2206710T3 publication Critical patent/PL2206710T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Endocrinology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Hematology (AREA)
Obesity (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)

PL10158582T 2006-12-21 2007-12-19 Pochodne indolu jako agoniści receptora S1P1 PL2206710T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0625647A GB0625647D0 (en)	2006-12-21	2006-12-21	Compounds
GB0707615A GB0707615D0 (en)	2007-04-19	2007-04-19	Compounds
EP10158582A EP2206710B1 (en)	2006-12-21	2007-12-19	Indole derivatives as S1P1 receptor agonists
EP07857808A EP2091949B1 (en)	2006-12-21	2007-12-19	Indole derivatives as s1p1 receptor agonists

Publications (1)

Publication Number	Publication Date
PL2206710T3 true PL2206710T3 (pl)	2012-11-30

Family

ID=39283563

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10158582T PL2206710T3 (pl)	2006-12-21	2007-12-19	Pochodne indolu jako agoniści receptora S1P1
PL07857808T PL2091949T3 (pl)	2006-12-21	2007-12-19	Pochodne indolu jako agoniści receptora S1P1

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL07857808T PL2091949T3 (pl)	2006-12-21	2007-12-19	Pochodne indolu jako agoniści receptora S1P1

Country Status (32)

Country	Link
US (1)	US8101775B2 (pl)
EP (2)	EP2206710B1 (pl)
JP (1)	JP5309034B2 (pl)
KR (1)	KR101495927B1 (pl)
CN (1)	CN103012390B (pl)
AR (1)	AR064452A1 (pl)
AT (1)	ATE509927T1 (pl)
AU (1)	AU2007336224B2 (pl)
BR (1)	BRPI0721127A2 (pl)
CA (1)	CA2673468C (pl)
CL (1)	CL2007003755A1 (pl)
CR (2)	CR10922A (pl)
CY (2)	CY1111702T1 (pl)
DK (2)	DK2091949T3 (pl)
DO (1)	DOP2009000133A (pl)
EA (1)	EA017406B1 (pl)
ES (1)	ES2389879T3 (pl)
HR (2)	HRP20110456T1 (pl)
IL (1)	IL199187A (pl)
JO (1)	JO2701B1 (pl)
MA (1)	MA30999B1 (pl)
MX (1)	MX2009006882A (pl)
MY (2)	MY156822A (pl)
NO (1)	NO20092385L (pl)
NZ (1)	NZ577387A (pl)
PE (2)	PE20121076A1 (pl)
PL (2)	PL2206710T3 (pl)
PT (2)	PT2206710E (pl)
SG (1)	SG177914A1 (pl)
SI (2)	SI2091949T1 (pl)
TW (1)	TWI393564B (pl)
WO (1)	WO2008074821A1 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2008012738A (es)	2006-04-03	2009-02-06	Astellas Pharma Inc	Heterocompuesto.
JO2701B1 (en)	2006-12-21	2013-03-03	جلاكسو جروب ليميتد	Vehicles
BRPI0809472A2 (pt) *	2007-04-19	2014-09-09	Glaxo Group Ltd	Derivados indazol substituídos com oxadiazol para emprego como agonistas de esfingosina 1-fosfato (sip)
GB0807910D0 (en)	2008-04-30	2008-06-04	Glaxo Group Ltd	Compounds
PL2913326T3 (pl)	2008-05-14	2020-11-16	The Scripps Research Institute	Nowe modulatory receptorów fosforanu sfingozyny
WO2009151621A1 (en) *	2008-06-13	2009-12-17	Arena Pharmaceuticals, Inc.	Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
WO2009151626A1 (en) *	2008-06-13	2009-12-17	Arena Pharmaceuticals, Inc.	Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
JP2011524880A (ja) *	2008-06-20	2011-09-08	グラクソグループリミテッド	化合物
SI2326621T1 (sl)	2008-07-23	2016-10-28	Arena Pharmaceuticals, Inc.	Substituirani derivati 1,2,3,4-tetrahidrociklopenta(b)indol-3-il)ocetne kisline, uporabni pri zdravljenju avtoimunskih in vnetnih motenj
SI2307007T1 (sl) *	2008-07-23	2014-11-28	Novartis Ag	Modulatorji sfingozin 1 fosfatnega receptorja in njihova uporaba za zdravljenje mišičnega vnetja
NZ591001A (en) *	2008-08-27	2012-11-30	Arena Pharm Inc	Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
EP2376484B1 (en) *	2008-12-18	2015-04-22	Merck Serono S.A.	Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
EP2202232A1 (en) *	2008-12-26	2010-06-30	Laboratorios Almirall, S.A.	1,2,4-oxadiazole derivatives and their therapeutic use
EP2241558A1 (en) *	2009-04-03	2010-10-20	Merck Serono SA	Oxadiazole derivatives
GB0910667D0 (en) *	2009-06-19	2009-08-05	Glaxo Wellcome Mfg Pte Ltd	Novel compounds
GB0910689D0 (en) *	2009-06-19	2009-08-05	Glaxo Wellcome Mfg Pte Ltd	Novel compounds
WO2011005295A1 (en) *	2009-06-24	2011-01-13	Arena Pharmaceuticals, Inc.	Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
UA107360C2 (en) *	2009-08-05	2014-12-25	Biogen Idec Inc	Bicyclic aryl sphingosine 1-phosphate analogs
US8399451B2 (en)	2009-08-07	2013-03-19	Bristol-Myers Squibb Company	Heterocyclic compounds
HUE054000T2 (hu)	2009-11-13	2021-08-30	Receptos Llc	Szelektív szfingozin-1-foszfát-receptor modulátorok és királis szintézis eljárások
US20120283297A1 (en) *	2009-12-18	2012-11-08	Glaxo Wellcome House	Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
SG10201500639TA (en)	2010-01-27	2015-03-30	Arena Pharm Inc	Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN105503882B (zh) *	2010-03-03	2019-07-05	艾尼纳制药公司	制备s1p1受体调节剂及其晶体形式的方法
JP5735634B2 (ja)	2010-04-23	2015-06-17	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	スフィンゴシン−１−リン酸受容体１アゴニストとしての４−（５−イソオキサゾリルまたは５−ピラゾリル−１，２，４−オキサジアゾール−３−イル）−マンデル酸アミド化合物
JP5869579B2 (ja)	2010-09-24	2016-02-24	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	置換オキサジアゾール化合物およびそれらのｓ１ｐ１アゴニストとしての使用
ES2772258T3 (es)	2011-02-07	2020-07-07	Biogen Ma Inc	Agentes moduladores de S1P
EP2706999B1 (en)	2011-05-13	2019-08-28	Celgene International II Sàrl	Selective heterocyclic sphingosine 1 phosphate receptor modulators
EP2567959B1 (en)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
GB201202027D0 (en) *	2012-02-06	2012-03-21	Sareum Ltd	Pharmaceutical compounds
CN116850181A (zh)	2015-01-06	2023-10-10	艾尼纳制药公司	治疗与s1p1受体有关的病症的方法
AU2016284162A1 (en)	2015-06-22	2018-02-01	Arena Pharmaceuticals, Inc.	Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(Compound1) for use in SIP1 receptor-associated disorders
KR102481328B1 (ko) *	2016-07-22	2022-12-26	메드샤인 디스커버리 아이엔씨.	S1p1 작용제 및 이의 응용
US11278526B2 (en)	2016-09-29	2022-03-22	Receptos Llc	Compounds and methods for treating lupus
CA3053416A1 (en)	2017-02-16	2018-08-23	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
AU2018220521A1 (en)	2017-02-16	2019-09-05	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of primary biliary cholangitis
WO2019236757A1 (en)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the s1p1 receptor
CN110627778B (zh) *	2018-06-25	2023-01-24	中国科学院上海药物研究所	一类含有1,2,4-噁二唑环的化合物、其制备方法及其在免疫抑制药物中的应用
US11555015B2 (en)	2018-09-06	2023-01-17	Arena Pharmaceuticals, Inc.	Compounds useful in the treatment of autoimmune and inflammatory disorders
CA3156298A1 (en)	2019-10-31	2021-05-06	Laetitia POUZOL	Combination of a cxcr7 antagonist with an s1p1 receptor modulator
CA3158593A1 (en)	2019-12-03	2021-06-10	Seung Yup Paek	Sphingosine-1-phosphate receptor agonist, preparation method therefor, and pharmaceutical composition containing same as active ingredient
US20230146180A1 (en) *	2020-02-11	2023-05-11	Syngenta Crop Protection Ag	Pesticidally active cyclic amine compounds
EP4212156A1 (en)	2022-01-13	2023-07-19	Abivax	Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2025083549A1 (en)	2023-10-16	2025-04-24	Sun Pharma Advanced Research Company Limited	Methods and combinations of inhibitors of il-23 pathway and modulators of s1p signaling pathway for the treatment of autoimmune disorders

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3939238A1 (de)	1989-11-28	1991-05-29	Bayer Ag	Heterocyclisch substituierte acrylsaeureester
DE4002466A1 (de)	1990-01-28	1991-10-10	Bayer Ag	Substituierte 2-(6-(pyrimidinyl)-indo-l-yl)-acrylsaeureester
US5523312A (en)	1994-09-27	1996-06-04	Sterling Winthrop Inc.	Antipicornaviral agents
DE19620041A1 (de)	1996-05-17	1998-01-29	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten
DE19643037A1 (de)	1996-10-18	1998-04-23	Boehringer Ingelheim Kg	Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
JPH1180026A (ja)	1997-09-02	1999-03-23	Yoshitomi Pharmaceut Ind Ltd	新規免疫抑制剤、その使用方法およびその同定方法
JP2005533058A (ja)	2002-06-17	2005-11-04	メルク　エンド　カムパニー　インコーポレーテッド	Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
CN1788008A (zh) *	2003-05-15	2006-06-14	麦克公司	作为s1p受体激动剂的3－(2－氨基－1－氮杂环基)－5－芳基－1,2,4－噁二唑
EP1479675A1 (en)	2003-05-19	2004-11-24	Aventis Pharma Deutschland GmbH	Indazole-derivatives as factor Xa inhibitors
AU2004277947A1 (en)	2003-10-01	2005-04-14	Merck & Co., Inc.	3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
WO2005058848A1 (en)	2003-12-17	2005-06-30	Merck & Co., Inc.	(3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
US8039674B2 (en)	2004-06-23	2011-10-18	Ono Pharmaceutical Co., Ltd.	Compound having S1P receptor binding potency and use thereof
AU2005299851B2 (en)	2004-10-22	2011-03-17	Merck Sharp & Dohme Corp.	2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
ES2395929T3 (es)	2005-02-25	2013-02-18	Ono Pharmaceutical Co., Ltd.	Compuestos de indol para tratar trastornos respiratorios
RU2404178C2 (ru)	2005-03-23	2010-11-20	Актелион Фармасьютиклз Лтд	Новые производные тиофена в качестве агонистов рецептора сфингозин-1-фосфата-1
CA2605594A1 (en)	2005-04-22	2006-11-02	Daiichi Sankyo Company, Limited	Heterocyclic compound
WO2006131336A1 (en)	2005-06-08	2006-12-14	Novartis Ag	POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
CA2619101A1 (en)	2005-08-23	2007-03-01	Irm Llc	Immunosuppressant compounds and compositions
GB0601744D0 (en)	2006-01-27	2006-03-08	Novartis Ag	Organic compounds
JP2007262009A (ja) *	2006-03-29	2007-10-11	Dai Ichi Seiyaku Co Ltd	ヘテロアリール低級カルボン酸誘導体
MX2008012738A (es) *	2006-04-03	2009-02-06	Astellas Pharma Inc	Heterocompuesto.
KR101470659B1 (ko)	2006-09-07	2014-12-08	액테리온 파마슈티칼 리미티드	면역조절제로서 피리딘-4-일 유도체
JO2701B1 (en)	2006-12-21	2013-03-03	جلاكسو جروب ليميتد	Vehicles
BRPI0809472A2 (pt)	2007-04-19	2014-09-09	Glaxo Group Ltd	Derivados indazol substituídos com oxadiazol para emprego como agonistas de esfingosina 1-fosfato (sip)

2007
- 2007-12-17 JO JO2007554A patent/JO2701B1/en active
- 2007-12-19 MY MYPI2012004367A patent/MY156822A/en unknown
- 2007-12-19 CA CA2673468A patent/CA2673468C/en not_active Expired - Fee Related
- 2007-12-19 DK DK07857808.5T patent/DK2091949T3/da active
- 2007-12-19 ES ES10158582T patent/ES2389879T3/es active Active
- 2007-12-19 MY MYPI20092612A patent/MY148470A/en unknown
- 2007-12-19 MX MX2009006882A patent/MX2009006882A/es active IP Right Grant
- 2007-12-19 TW TW096148543A patent/TWI393564B/zh not_active IP Right Cessation
- 2007-12-19 SI SI200730670T patent/SI2091949T1/sl unknown
- 2007-12-19 HR HR20110456T patent/HRP20110456T1/hr unknown
- 2007-12-19 PL PL10158582T patent/PL2206710T3/pl unknown
- 2007-12-19 PT PT10158582T patent/PT2206710E/pt unknown
- 2007-12-19 CN CN201210396720.5A patent/CN103012390B/zh not_active Expired - Fee Related
- 2007-12-19 US US12/520,145 patent/US8101775B2/en not_active Expired - Fee Related
- 2007-12-19 EA EA200970612A patent/EA017406B1/ru not_active IP Right Cessation
- 2007-12-19 KR KR1020097012841A patent/KR101495927B1/ko not_active Expired - Fee Related
- 2007-12-19 NZ NZ577387A patent/NZ577387A/en not_active IP Right Cessation
- 2007-12-19 BR BRPI0721127-9A patent/BRPI0721127A2/pt not_active IP Right Cessation
- 2007-12-19 JP JP2009542043A patent/JP5309034B2/ja not_active Expired - Fee Related
- 2007-12-19 DK DK10158582.6T patent/DK2206710T3/da active
- 2007-12-19 EP EP10158582A patent/EP2206710B1/en active Active
- 2007-12-19 WO PCT/EP2007/064185 patent/WO2008074821A1/en not_active Ceased
- 2007-12-19 SI SI200731001T patent/SI2206710T1/sl unknown
- 2007-12-19 AU AU2007336224A patent/AU2007336224B2/en not_active Ceased
- 2007-12-19 SG SG2011095114A patent/SG177914A1/en unknown
- 2007-12-19 AR ARP070105729A patent/AR064452A1/es unknown
- 2007-12-19 PT PT07857808T patent/PT2091949E/pt unknown
- 2007-12-19 PL PL07857808T patent/PL2091949T3/pl unknown
- 2007-12-19 AT AT07857808T patent/ATE509927T1/de active
- 2007-12-19 EP EP07857808A patent/EP2091949B1/en active Active
- 2007-12-20 CL CL200703755A patent/CL2007003755A1/es unknown
2008
- 2008-01-02 PE PE2012000146A patent/PE20121076A1/es not_active Application Discontinuation
- 2008-01-02 PE PE2008000023A patent/PE20081398A1/es not_active Application Discontinuation
2009
- 2009-06-04 IL IL199187A patent/IL199187A/en not_active IP Right Cessation
- 2009-06-05 DO DO2009000133A patent/DOP2009000133A/es unknown
- 2009-06-17 MA MA32003A patent/MA30999B1/fr unknown
- 2009-06-23 NO NO20092385A patent/NO20092385L/no not_active Application Discontinuation
- 2009-07-13 CR CR10922A patent/CR10922A/es unknown
2011
- 2011-07-19 CY CY20111100700T patent/CY1111702T1/el unknown
2012
- 2012-08-29 HR HRP20120685TT patent/HRP20120685T1/hr unknown
- 2012-09-20 CY CY20121100862T patent/CY1113131T1/el unknown
2014
- 2014-07-01 CR CR20140316A patent/CR20140316A/es unknown

Also Published As

Publication number	Publication date
MA30999B1 (fr)	2009-12-01
SI2091949T1 (sl)	2011-08-31
KR101495927B1 (ko)	2015-02-25
PE20121076A1 (es)	2012-09-05
CA2673468A1 (en)	2008-06-26
EA017406B1 (ru)	2012-12-28
CA2673468C (en)	2015-06-02
PE20081398A1 (es)	2008-11-19
IL199187A0 (en)	2010-03-28
ATE509927T1 (de)	2011-06-15
IL199187A (en)	2015-04-30
DK2206710T3 (da)	2012-08-27
HK1140761A1 (en)	2010-10-22
WO2008074821A1 (en)	2008-06-26
CN103012390B (zh)	2015-08-26
CY1113131T1 (el)	2016-04-13
NZ577387A (en)	2012-01-12
EP2091949A1 (en)	2009-08-26
PT2091949E (pt)	2011-07-13
JO2701B1 (en)	2013-03-03
ES2389879T3 (es)	2012-11-02
TW200843736A (en)	2008-11-16
JP5309034B2 (ja)	2013-10-09
AU2007336224B2 (en)	2013-01-10
KR20090092290A (ko)	2009-08-31
MX2009006882A (es)	2009-07-03
HRP20120685T1 (hr)	2012-09-30
BRPI0721127A2 (pt)	2014-03-11
CN103012390A (zh)	2013-04-03
PT2206710E (pt)	2012-09-10
AR064452A1 (es)	2009-04-01
HRP20110456T1 (hr)	2011-07-31
EP2206710B1 (en)	2012-07-04
HK1130255A1 (en)	2009-12-24
CR20140316A (es)	2014-08-20
PL2091949T3 (pl)	2011-10-31
DK2091949T3 (da)	2011-07-18
AU2007336224A1 (en)	2008-06-26
TWI393564B (zh)	2013-04-21
CL2007003755A1 (es)	2008-08-22
MY156822A (en)	2016-03-31
DOP2009000133A (es)	2009-08-15
CR10922A (es)	2009-08-12
SI2206710T1 (sl)	2012-10-30
SG177914A1 (en)	2012-02-28
US20100113796A1 (en)	2010-05-06
MY148470A (en)	2013-04-30
EA200970612A1 (ru)	2009-10-30
US8101775B2 (en)	2012-01-24
CY1111702T1 (el)	2015-10-07
EP2091949B1 (en)	2011-05-18
EP2206710A1 (en)	2010-07-14
NO20092385L (no)	2009-08-24
JP2010513397A (ja)	2010-04-30

Publication	Publication Date	Title
IL199187A0 (en)	2010-03-28	Indole derivatives as s1p1 receptor agonists
IL192657A (en)	2015-09-24	Theophenic history as 1edg / 1p1s receptor agonists
IL197395A0 (en)	2009-12-24	Thiophene derivatives as s1p1/edg1 receptor agonists
ZA200706420B (en)	2009-04-29	Oxyindole derivatives as 5HT4 receptor agonists
ZA200806392B (en)	2009-06-24	Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as SIP receptor agonists
IL200911A0 (en)	2010-05-17	Amino-pyridine derivatives as s1p1/edg1 receptor agonists
IL198931A0 (en)	2010-02-17	Benzamide derivatives as ep4 receptor agonists
IL186150A0 (en)	2008-01-20	Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists
ZA200709086B (en)	2008-12-31	Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
PT2003132E (pt)	2014-05-26	Derivados de oxadiazole como agonistas dos s1p1
EP2049520A4 (en)	2011-01-05	indole compounds
IL207684A0 (en)	2010-12-30	Substituted indole derivatives
IL186883A0 (en)	2008-02-09	Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
ZA200905265B (en)	2010-04-28	Indole derivatives
ZA200707142B (en)	2008-10-29	Quinolinone compounds as 5-HT4 receptor agonists
ZA200900843B (en)	2010-03-31	Indole compounds
IL198683A0 (en)	2010-02-17	Indoles which act as via receptor antagonists
ZA200903829B (en)	2010-04-28	Indole derivatives as S1P1 receptor agonists
HK1132728A (en)	2010-03-05	Benzamide derivatives as ep4 receptor agonists
HK1121754A (en)	2009-04-30	Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
ZA200709829B (en)	2008-11-26	Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
AU2008903337A0 (en)	2008-07-17	TPOR Receptor Agonists
AU2008903336A0 (en)	2008-07-17	TPOR Receptor Agonists